In accordance with the recent report by, Credence Research, Inc. “Interventional Cardiology and Peripheral Vascular Devices Market: Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global interventional cardiology and peripheral vascular devices market was valued at US$ 14.53 Bn in 2016, growing at a CAGR of 8.8%.
Browse the full report Interventional Cardiology and Peripheral Vascular Devices Market– Growth, Future Prospects and Competitive Analysis, 2017-2025 report at http://www.credenceresearch.com/report/interventional-cardiology-peripheral-vascular-devices-market
Interventional cardiology and peripheral vascular treatment is a preferred alternative to traditional open surgical procedure in cardiovascular disease treatment. Interventional approaches are gaining acceptance in the medical fraternity for treating cardiac disorders and peripheral vascular diseases for being safe and efficient in terms of treatment outcome. The interventional cardiology and peripheral vascular devices market is expected to witness steady growth due to enhanced personal satisfaction of patients experiencing coronary heart disease and peripheral vascular disorders. In the future interventional approach will continue to expand since new technologies take over open surgeries.
The global interventional cardiology and peripheral vascular devices market growth is fuelled by increasing cardiovascular ailments and subsequent high rate of death across the world since heart disease caused 633,000 death of Americans in the year 2015, as per data reported by the National Center for Health Statistics. Peripheral arterial disease affect more than 10 million patients, causing further discomfort and serious complications. Sedentary lifestyle with fat-enriched diet habit, increasing tobacco and alcohol consumption, and stress act as triggering factors for cardiovascular diseases. Apart from these, other two major risk factors of cardiovascular diseases are diabetes and obesity which are also on rise, and would successively boost market growth. Adoption of evolving technology in healthcare facilities, increasing number of cardiac catheterization laboratories and increasing fund for ongoing cardiovascular research have positive impact on the market growth.
Market Competition Assessment:
The major industry players of interventional cardiology and peripheral vascular devices market having interventional cardiology and peripheral vascular devices market includes Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., St. Jude Medical, Abbott Laboratories, C. R. Bard, Inc., Medtronic plc., Edwards Lifesciences Corporation, Terumo Corporation, B. Braun Melsungen AG, Baxter International Inc., 3M Company, and other notable players.
Key Market Movements:
- Increasing geriatric population, growing prevalence of cardiovascular disease, rising focus into treatment with lesser complication and improved outcomes, inclining trend towards minimally invasive procedure acted as major drivers of the interventional cardiology and peripheral vascular devices market.
- Conventional treatment and medication are considered to act as threats for interventional cardiology and peripheral vascular devices market.
Download sample research report @ http://www.credenceresearch.com/sample-request/58895
Table Of Content:
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Interventional Cardiology & Peripheral Vascular Devices Market Portraiture
2.1.1. Global Interventional Cardiology & Peripheral Vascular Devices Market, by Product Type, 2016 (US$ Mn)
2.1.2. Global Interventional Cardiology & Peripheral Vascular Devices Market, by Geography, 2016 vs. 2025 (Value %)
Chapter 3. Interventional Cardiology & Peripheral Vascular Devices Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Interventional Cardiology & Peripheral Vascular Devices: Future Trends
3.6. Porter’s Five Forces Analysis …
Chapter 6. Company Profiles
6.1. Abbott Laboratories
220.127.116.11. Business Description
18.104.22.168. Financial Information (Subject to data availability)
22.214.171.124. Product Portfolio
126.96.36.199. Key Developments
6.2. B. Braun Melsungen AG
6.3. Baxter International Inc.
6.4. Boston Scientific Corporation
6.5. C. R. Bard, Inc.
6.6. Cardinal Health …
Request for customization research report @ http://www.credenceresearch.com/request-for-customization/58895
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: Send Email
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
Country: United States